Tech Company Financing Transactions
Kinaset Therapeutics Funding Round
Kinaset Therapeutics, based in Medfield, secured $40 million from 5AM Ventures, Atlas Venture and GIMV.
Transaction Overview
Company Name
Announced On
12/1/2020
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10 Knollwood Rd.
Medfield, MA 02052
USA
Medfield, MA 02052
USA
Phone
Website
Email Address
Overview
Kinaset Therapeutics intends to develop novel therapeutics that can positively impact people affected by intractable diseases, including severe asthma. The firm's novel lead asset and experienced team combine a potentially best in class approach to treating severe asthma with a group of dedicated drug development experts working to bring the therapy forward.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Clarke
VP - Bus. Development
Roger Heerman
VP - Bus. Development
Frazer Morgan
Browse more venture capital transactions:
Prev: 12/1/2020: PureFacts Financial Solutions venture capital transaction
Next: 12/1/2020: Totum Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs